Anti-Siglec-2/CD22 Antibody (NCI m971) is a highly specialized fully human monoclonal antibody fragment target the Siglec-2 surface antigen with exceptional binding affinity, internalization of the antibody-receptor complex across various preclinical experimental models of B-cell malignancies to evaluate cytotoxic efficacy.
Target:
Immunology/Inflammation related
T9901A-1474
* VAT and and shipping costs not included. Errors and price changes excepted
